Valeria Ferrero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Valeria Ferrero has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Corrado Vassanelli
3 shared publications- Flavio Ribichini
Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
3 shared publications Flavio Ribichini
2 shared publications- Gabriele Pesarini
University of Verona
2 shared publications - Giuseppe Matullo
Department of Medical Sciences, University of Turin, Turin, Italy
2 shared publications Guy R. Heyndrickx
2 shared publications
Latest Publications
- 29 March 2013
- Published by SAGE Publications in Journal Of Nephrology
- Vol. 26 (3) , 586-593
Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology
Contrast-induced nephropathy (CI-AKI) is a complication of diagnostic/therapeutic hemodynamic procedures in cardiology, which may also cause renal cholesterolinic atheroembolism. Despite the severe clinical impact of these complications, there is no optimal therapy for preventing and treating them. We suggest a short course of high-dose steroids as an effective preventive measure.
- 29 March 2013
- Published by SAGE Publications in Journal Of Nephrology
- Vol. 26 (3) , 586-593
Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology
Contrast-induced nephropathy (CI-AKI) is a complication of diagnostic/therapeutic hemodynamic procedures in cardiology, which may also cause renal cholesterolinic atheroembolism. Despite the severe clinical impact of these complications, there is no optimal therapy for preventing and treating them. We suggest a short course of high-dose steroids as an effective preventive measure.
- 1 March 2009
- Vol. 21 (3) , 86-91
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry.
Steroids have known powerful anti-inflammatory effects. This study was designed to assess the possible antiproliferative action of the Dexamet(R)dexamethasone-loaded stent. This was a prospective, controlled registry performed in 20 Italian centers that enrolled 332 patients with acute coronary syndromes (ACS) treated according to an early-invasive approach with the implantation of 420 dexamethasone-eluting stents in 387 coronary lesions. Six of the enrolling centers participated in the angiographic substudy: elective 6-month follow-up angiography was performed in 140/151 patients (92.7%). Quantitative coronary analysis (QCA) was performed at a centralized core laboratory on 156 lesions treated with the Dexamet stent. One hundred forty patients (156 lesions) underwent elective QCA. Patients presented with either unstable angina (80%) or Non-ST-elevation myocardial infarction (20%); 70 patients (50%) had ST-T segment changes, 81 (58%) had troponin elevation and 31 (22.1%) were diabetic. One hundred twenty-five patients had a single lesion, 117 of which were treated with a single stent, while 8 received multiple stents. Mean lesion and stent lengths were 11.94 +/- 6.30 and 17.30 +/- 6.08 mm, respectively. In-segment binary restenosis (percent [%] diameter stenosis >/= 50%) was 34.3% per patient (48/140), or 33.3% per lesion (52/156); the mean late lumen loss was 0.95 +/- 0.64 mm in-stent and 1.02 +/- 0.59 mm in-segment. At multivariate analysis, baseline minimum luminal diameter (MLD) (MLD - odds ratio [OR] = 0.18; 95% confidence interval [CI] = 0.04-0.72; p = 0.01) and lesion length (OR = 1.12; 95% CI = 1.04-1.2; p < 0.01) were independent predictors of 6-months binary restenosis This is the first large, multicenter analysis of the angiographic outcome obtained with Dexamet. Our results do not support any effective antiproliferative action of this device implanted in patients with ACS.
- 1 March 2009
- Vol. 21 (3) , 86-91
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry.
Steroids have known powerful anti-inflammatory effects. This study was designed to assess the possible antiproliferative action of the Dexamet(R)dexamethasone-loaded stent. This was a prospective, controlled registry performed in 20 Italian centers that enrolled 332 patients with acute coronary syndromes (ACS) treated according to an early-invasive approach with the implantation of 420 dexamethasone-eluting stents in 387 coronary lesions. Six of the enrolling centers participated in the angiographic substudy: elective 6-month follow-up angiography was performed in 140/151 patients (92.7%). Quantitative coronary analysis (QCA) was performed at a centralized core laboratory on 156 lesions treated with the Dexamet stent. One hundred forty patients (156 lesions) underwent elective QCA. Patients presented with either unstable angina (80%) or Non-ST-elevation myocardial infarction (20%); 70 patients (50%) had ST-T segment changes, 81 (58%) had troponin elevation and 31 (22.1%) were diabetic. One hundred twenty-five patients had a single lesion, 117 of which were treated with a single stent, while 8 received multiple stents. Mean lesion and stent lengths were 11.94 +/- 6.30 and 17.30 +/- 6.08 mm, respectively. In-segment binary restenosis (percent [%] diameter stenosis >/= 50%) was 34.3% per patient (48/140), or 33.3% per lesion (52/156); the mean late lumen loss was 0.95 +/- 0.64 mm in-stent and 1.02 +/- 0.59 mm in-segment. At multivariate analysis, baseline minimum luminal diameter (MLD) (MLD - odds ratio [OR] = 0.18; 95% confidence interval [CI] = 0.04-0.72; p = 0.01) and lesion length (OR = 1.12; 95% CI = 1.04-1.2; p < 0.01) were independent predictors of 6-months binary restenosis This is the first large, multicenter analysis of the angiographic outcome obtained with Dexamet. Our results do not support any effective antiproliferative action of this device implanted in patients with ACS.
- 1 March 2007
- Published by Elsevier in American Heart Journal
- Vol. 153 (3) , 398-402
Intracoronary β-irradiation for the treatment of de novo lesions: 5-Year clinical follow-up of the BetAce randomized trial
- 1 March 2007
- Published by Elsevier in American Heart Journal
- Vol. 153 (3) , 398-402
Intracoronary β-irradiation for the treatment of de novo lesions: 5-Year clinical follow-up of the BetAce randomized trial
- 15 November 2004
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (10) , 1237-1242
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
- 15 November 2004
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (10) , 1237-1242
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
- 1 November 2001
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 14 (11) , A186-A187
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is not correlated to the stable or unstable presentation of patients with coronary artery disease
The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene has been proposed as an independent risk factor for myocardial infarction (MI) and coronary artery disease (CAD). Although results are controversial, the D allele seems to bear a stronger relationship with MI than with the degree of CAD. In fact, the I/D polymorphism was found to be somehow related to the conversion of stable coronary syndromes into MI, independently of the presence and the severity of coronary lesions. We assessed the I/D polymorphism of the ACE gene using conventional PCR in 422 symptomatic ischemic patients referred to our catheterization unit; a second independent PCR was performed in D/D patients using specific primers to avoid D allele underestimation. Patients were classified as having stable (n=176) or unstable angina (n=246). Both groups were in Hardy-Weinberg equilibrium. The genotype distribution and the D allele frequency (p) in the two groups are shown in the table. Conclusion: The D allele of the ID polymorphism of the ACE gene seems not to be associated with a higher incidence of an unstable presentation of CAD in a selected population of symptomatic patients undergoing coronary angiography.
- 1 November 2001
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 14 (11) , A186-A187
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is not correlated to the stable or unstable presentation of patients with coronary artery disease
The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene has been proposed as an independent risk factor for myocardial infarction (MI) and coronary artery disease (CAD). Although results are controversial, the D allele seems to bear a stronger relationship with MI than with the degree of CAD. In fact, the I/D polymorphism was found to be somehow related to the conversion of stable coronary syndromes into MI, independently of the presence and the severity of coronary lesions. We assessed the I/D polymorphism of the ACE gene using conventional PCR in 422 symptomatic ischemic patients referred to our catheterization unit; a second independent PCR was performed in D/D patients using specific primers to avoid D allele underestimation. Patients were classified as having stable (n=176) or unstable angina (n=246). Both groups were in Hardy-Weinberg equilibrium. The genotype distribution and the D allele frequency (p) in the two groups are shown in the table. Conclusion: The D allele of the ID polymorphism of the ACE gene seems not to be associated with a higher incidence of an unstable presentation of CAD in a selected population of symptomatic patients undergoing coronary angiography.